CASIA OpenIR
Topiramate and Metformin Are Effective Add-On Treatments in Controlling Antipsychotic-Induced Weight Gain: A Systematic Review and Network Meta-Analysis
Zhuo, Chuanjun1,2,3,4,5,6; Xu, Yong4,5,6; Liu, Sha4,5,6; Li, Jing4,5,6; Zheng, Qishi7; Gao, Xiangyang8; Li, Shen3; Jing, Rixing9; Song, Xueqin10; Yue, Weihua11,12,13; Zhou, Chunhua14; Upthegrove, Rachel15,16
Source PublicationFRONTIERS IN PHARMACOLOGY
ISSN1663-9812
2018-11-28
Volume9Pages:10
Corresponding AuthorZhuo, Chuanjun(chuanjunzhuotjmh@163.com) ; Yue, Weihua(dryue@bjmu.edu.cn) ; Zhou, Chunhua(zhouchunhua80@126.com)
AbstractBackground: Antipsychotic drugs may lead to side effects such as obesity, diabetes, dyslipidemia, and cardiovascular disease. The current systematic review and network meta-analysis analyzes and provides an update on the clinical performance of these add-ons in comparison to placebo on body weight and body mass index (BMI) reductions. Methods: A comprehensive literature search was performed on electronic databases: PubMed (1946-), Embase (1974-), Cochrane library (1992-), and OpenGrey (2000-) until 31 July 2018. Network meta-analyses, comparing the body weight change, BMI change and withdrawn due to adverse events of different pharmacological add-ons, was performed using a multivariate meta-regression model with random-effects, adopting a frequentist approach. To rank the prognosis for all add-ons, we used surface under the cumulative ranking (SUCRA) values. Outcomes: From 614 potential studies identified, 27 eligible studies (n = 1,349 subjects) were included. All the studies demonstrated low to moderate risk of bias. For the analysis of body weight change, all add-ons except Ranitidine showed significant weight reductions comparing to placebo. The effectiveness rank based on SUCRA results from highest to lowest was Sibutramine, Topiramate, Metformin, Reboxetine, Ranitidine, and placebo. A similar pattern was seen for BMI change. The analysis of safety outcome did not detect significantly increased withdrawn number from the add-ons. Current evidence showed relatively good tolerance and safety of using the pharmacological add-ons. Interpretation: Topiramate and Metformin are effective add-on treatments in controlling antipsychotic-induced weight gain, comparing to placebo. They are well tolerated in short-term period. Although Sibutramine has the highest rank of the effectiveness, its license has been withdrawn in many countries due to its adverse effects. Hence, Sibutramine should not be adopted to treat antipsychotic-induced weight gain.
Keywordantipsychotic-induced weight gain network meta-analysis pharmacological add-ons topiramate metformin
DOI10.3389/fphar.2018.01393
WOS KeywordPLACEBO-CONTROLLED TRIAL ; OLANZAPINE-TREATED PATIENTS ; AUTISM SPECTRUM DISORDER ; DOUBLE-BLIND ; BODY-WEIGHT ; METABOLIC DYSFUNCTION ; OPEN-LABEL ; 1ST-EPISODE SCHIZOPHRENIA ; OBESE-PATIENTS ; YOUNG-PEOPLE
Indexed BySCI
Language英语
Funding ProjectTianjin Health Bureau Foundation[2014KR02] ; National Natural Science Foundation of China[81871052] ; National Natural Science Foundation of China[81701326] ; National Natural Science Foundation of China[81571319] ; Key Projects of the Natural Science Foundation of Tianjin, China[17JCZDJC35700] ; National Key Research and Development Program of China[2016YFC1307004] ; Multidisciplinary Team for Cognitive Impairment of Shanxi Science and Technology Innovation Training Team[201705D131027]
Funding OrganizationTianjin Health Bureau Foundation ; National Natural Science Foundation of China ; Key Projects of the Natural Science Foundation of Tianjin, China ; National Key Research and Development Program of China ; Multidisciplinary Team for Cognitive Impairment of Shanxi Science and Technology Innovation Training Team
WOS Research AreaPharmacology & Pharmacy
WOS SubjectPharmacology & Pharmacy
WOS IDWOS:000451647300001
PublisherFRONTIERS MEDIA SA
Citation statistics
Document Type期刊论文
Identifierhttp://ir.ia.ac.cn/handle/173211/25702
Collection中国科学院自动化研究所
Corresponding AuthorZhuo, Chuanjun; Yue, Weihua; Zhou, Chunhua
Affiliation1.Tianjin Med Univ, Tianjin Anding Hosp, Dept Psychiat & Morbid, Tianjin, Peoples R China
2.Jining Med Univ, Dept Psychiat, Jining, Peoples R China
3.Tianjin Med Univ, Dept Psychiat, Tianjin, Peoples R China
4.Shanxi Med Univ, Hosp 1, Clin Med Coll 1, Dept Psychiat, Taiyuan, Shanxi, Peoples R China
5.Shanxi Med Univ, Hosp 1, MDT Ctr Cognit Impairment & Sleep Disorders, Taiyuan, Shanxi, Peoples R China
6.Shanxi Med Univ, Minist Educ, Key Lab Cellular Physiol, Dept Neurobiol,Natl Key Disciplines, Taiyuan, Shanxi, Peoples R China
7.Singapore Clin Res Inst, Dept Epidemiol, Singapore, Singapore
8.Chinese Peoples Liberat Army Gen Hosp, Big Data Anal Ctr, Hlth Management Inst, Beijing, Peoples R China
9.Chinese Acad Sci, Inst Automat, China Natl Key Lab, Dept Pattern Recognit, Beijing, Peoples R China
10.Zhengzhou Univ, Affiliated Hosp 1, Dept Psychiat, Zhengzhou, Henan, Peoples R China
11.Peking Univ, Hosp 6, Inst Mental Hlth, Beijing, Peoples R China
12.Peking Univ, Minist Hlth, Key Lab Mental Hlth, Beijing, Peoples R China
13.Peking Univ, Natl Clin Res Ctr Mental Disorders, Beijing, Peoples R China
14.Hebei Med Univ, Hosp 1, Dept Pharm, Shijiazhuang, Hebei, Peoples R China
15.Univ Birmingham, Inst Mental Hlth, Birmingham, W Midlands, England
16.Forward Thinking Birmingham, Early Intervent Serv, Birmingham, W Midlands, England
Recommended Citation
GB/T 7714
Zhuo, Chuanjun,Xu, Yong,Liu, Sha,et al. Topiramate and Metformin Are Effective Add-On Treatments in Controlling Antipsychotic-Induced Weight Gain: A Systematic Review and Network Meta-Analysis[J]. FRONTIERS IN PHARMACOLOGY,2018,9:10.
APA Zhuo, Chuanjun.,Xu, Yong.,Liu, Sha.,Li, Jing.,Zheng, Qishi.,...&Upthegrove, Rachel.(2018).Topiramate and Metformin Are Effective Add-On Treatments in Controlling Antipsychotic-Induced Weight Gain: A Systematic Review and Network Meta-Analysis.FRONTIERS IN PHARMACOLOGY,9,10.
MLA Zhuo, Chuanjun,et al."Topiramate and Metformin Are Effective Add-On Treatments in Controlling Antipsychotic-Induced Weight Gain: A Systematic Review and Network Meta-Analysis".FRONTIERS IN PHARMACOLOGY 9(2018):10.
Files in This Item:
There are no files associated with this item.
Related Services
Recommend this item
Bookmark
Usage statistics
Export to Endnote
Google Scholar
Similar articles in Google Scholar
[Zhuo, Chuanjun]'s Articles
[Xu, Yong]'s Articles
[Liu, Sha]'s Articles
Baidu academic
Similar articles in Baidu academic
[Zhuo, Chuanjun]'s Articles
[Xu, Yong]'s Articles
[Liu, Sha]'s Articles
Bing Scholar
Similar articles in Bing Scholar
[Zhuo, Chuanjun]'s Articles
[Xu, Yong]'s Articles
[Liu, Sha]'s Articles
Terms of Use
No data!
Social Bookmark/Share
All comments (0)
No comment.
 

Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.